Medicines
MDPI AG · Switzerland
Aims & Scope✦ Inferred from recent articles
Medicines focuses on the pharmacological aspects of health and disease. The journal publishes research on drug efficacy, safety, and mechanisms of action, including studies on antimicrobial agents, analgesics, chemopreventive compounds, and treatments for chronic conditions like cancer, cardiovascular diseases, and neurological disorders. It also covers drug interactions, pharmacokinetics, and the development of novel drug delivery systems.
AI-summarised from recent articles · verify on publisher page →
General Information
Submission Info
Ethics & Quality
Think.Check.Submit Compliance
Based on the Think.Check.Submit framework by DOAJ, COPE & OASPA. All data from verified open sources.
Subject Classification
Research Topics (OpenAlex)
Frequently asked questions about Medicines
Is Medicines a predatory journal?
PubScope has no integrity flags on record for Medicines: it is indexed in DOAJ, and is not on DOAJ's withdrawn list. Its PubScope Trust Score is 62/100. Indexing is a transparency signal, not a guarantee — always confirm fit and policies before submitting.
What is the impact factor of Medicines?
Medicines is not in the Web of Science Core Collection, so it has no official Clarivate Journal Impact Factor.
Is Medicines indexed in Scopus and Web of Science?
Medicines is indexed in DOAJ.
How much does it cost to publish in Medicines?
Medicines charges an article processing charge (APC) of about CHF 1,400 for open-access publication.
You May Also Like
See all →Data updated: 2026-05-26 · Sources: SJR, DOAJ, OpenAlex, WoS, Crossref